These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21146469)

  • 1. Drug response profiles to experimental pain are opioid and pain modality specific.
    Kindler LL; Sibille KT; Glover TL; Staud R; Riley JL; Fillingim RB
    J Pain; 2011 Mar; 12(3):340-51. PubMed ID: 21146469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual differences in morphine and butorphanol analgesia: a laboratory pain study.
    Sibille KT; Kindler LL; Glover TL; Gonzalez RD; Staud R; Riley JL; Fillingim RB
    Pain Med; 2011 Jul; 12(7):1076-85. PubMed ID: 21668741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.
    Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Kinner E; Schuster E; Passik S; France CR
    Pain; 2013 Sep; 154(9):1856-1864. PubMed ID: 23748117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in analgesia: a randomized trial of mu versus kappa opioid agonists.
    Miller PL; Ernst AA
    South Med J; 2004 Jan; 97(1):35-41. PubMed ID: 14746420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor.
    Smith MA; Barrett AC; Picker MJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the pain-reducing effect of opioid medication reliable? A psychophysical study of morphine and pentazocine analgesia.
    King CD; Goodin B; Glover TL; Riley JL; Hou W; Staud R; Fillingim RB
    Pain; 2013 Mar; 154(3):476-483. PubMed ID: 23438853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.
    Ho KWD; Wallace MR; Staud R; Fillingim RB
    Pharmacogenomics J; 2020 Jun; 20(3):471-481. PubMed ID: 31806881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose effects of morphine and butorphanol alone and in combination after burn injury in the rat.
    Osgood PF; Kazianis A; Kemp JW; Atchison NE; Carr DB; Szyfelbein SK
    J Burn Care Rehabil; 1995; 16(4):394-9. PubMed ID: 8582918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of epidural butorphanol versus epidural morphine in postoperative pain relief.
    Parikh GP; Veena SR; Vora K; Parikh B; Joshi A
    Middle East J Anaesthesiol; 2014 Feb; 22(4):371-6. PubMed ID: 25007690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.
    Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM
    Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia.
    Fillingim RB; Ness TJ; Glover TL; Campbell CM; Hastie BA; Price DD; Staud R
    J Pain; 2005 Feb; 6(2):116-24. PubMed ID: 15694878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized clinical trial evaluating the analgesic efficacy of ketorolac versus butorphanol for patients with suspected biliary colic in the emergency department.
    Olsen JC; McGrath NA; Schwarz DG; Cutcliffe BJ; Stern JL
    Acad Emerg Med; 2008 Aug; 15(8):718-22. PubMed ID: 18637080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.
    Olesen AE; Staahl C; Arendt-Nielsen L; Drewes AM
    Br J Clin Pharmacol; 2010 Aug; 70(2):189-200. PubMed ID: 20653672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.
    Morgan D; Cook CD; Smith MA; Picker MJ
    Anesth Analg; 1999 Feb; 88(2):407-13. PubMed ID: 9972766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-affective and somatic side effects of morphine and pentazocine: side-effect profiles in healthy adults.
    Riley JL; Hastie BA; Glover TL; Fillingim RB; Staud R; Campbell CM
    Pain Med; 2010 Feb; 11(2):195-206. PubMed ID: 19671086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of kappa opioid receptors in the formalin-induced inhibition of analgesic tolerance to morphine via suppression of conventional protein kinase C activation.
    Fujita-Hamabe W; Nagae R; Nawa A; Harada S; Nakamoto K; Tokuyama S
    J Pharm Pharmacol; 2010 Aug; 62(8):995-1002. PubMed ID: 20663033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.